| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.4 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic was found in IBM Security Secret Server 10.7. This vulnerability affects unknown code of the component Web UI. The manipulation results in cross site scripting. This vulnerability was named CVE-2020-4323. The attack may be performed from remote. There is no available exploit.
Details
A vulnerability classified as problematic has been found in IBM Security Secret Server 10.7. Affected is an unknown function of the component Web UI. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. This is going to have an impact on integrity. CVE summarizes:
IBM Security Secret Server 10.7 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 177514.
The weakness was presented 06/24/2020 (Website). The advisory is shared for download at ibm.com. This vulnerability is traded as CVE-2020-4323 since 12/30/2019. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 06/26/2020). It is expected to see the exploit prices for this product increasing in the near future.The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
See VDB-157252, VDB-157251, VDB-157250 and VDB-157249 for similar entries. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.4
VulDB Base Score: 4.7
VulDB Temp Score: 4.7
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/30/2019 🔍06/24/2020 🔍
06/26/2020 🔍
10/27/2020 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2020-4323 (🔍)
GCVE (CVE): GCVE-0-2020-4323
GCVE (VulDB): GCVE-100-157248
X-Force: 177514
See also: 🔍
Entry
Created: 06/26/2020 07:58Updated: 10/27/2020 08:15
Changes: 06/26/2020 07:58 (39), 06/26/2020 08:03 (11), 10/27/2020 08:11 (2), 10/27/2020 08:15 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.